Search Results - "Shanti Natarajan-Amé"
-
1
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Published in Clinical infectious diseases (01-11-2008)“…Background. Invasive aspergillosis is associated with high death rates. Factors associated with increased mortality have not yet been identified in a large…”
Get full text
Journal Article -
2
Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera
Published in International journal of infectious diseases (01-03-2019)“…•Patients treated with ruxolitinib are at higher risk of mycobacterial infection.•Tuberculosis under ruxolitinib can occur without any prior…”
Get full text
Journal Article -
3
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib
Published in Clinical pharmacokinetics (01-07-2020)“…Dasatinib is an oral, once-daily tyrosine kinase inhibitor used in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute…”
Get full text
Journal Article -
4
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM
Published in British journal of haematology (01-07-2012)“…Summary Marrow cells from patients with higher‐risk myelodysplastic syndrome (MDS) exhibit constitutive nuclear factor (NF)‐κB activation. The proteasome…”
Get full text
Journal Article -
5
-
6
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?
Published in Blood (26-09-2013)Get full text
Journal Article -
7
Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients
Published in Journal of clinical oncology (01-04-2002)“…To assess the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) in the diagnosis of invasive aspergillosis (IA) in adult and pediatric…”
Get full text
Journal Article -
8
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
Published in Leukemia research (01-11-2011)“…Abstract We evaluated the prognostic value of serum ferritin (SF) level at diagnosis in 318 newly diagnosed IPSS low and int 1 (lower) risk MDS patients…”
Get full text
Journal Article -
9
Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level
Published in Annals of hematology (01-01-2012)“…Myelodysplastic syndromes (MDS) are associated with increased bone marrow vascularity and increased levels of various angiogenic factors including Vascular…”
Get full text
Journal Article -
10
Can combination salvage therapy for invasive aspergillosis improve patient outcome?
Published in Nature clinical practice. Oncology (01-04-2005)Get full text
Journal Article -
11
Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients
Published in Blood (16-11-2006)“…Despite recent progresses in treatment, invasive aspergillosis (IA) is still associated with high treatment failure and elevated death rates. Prognostic…”
Get full text
Journal Article -
12
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases
Published in Clinical and experimental medicine (01-07-2023)“…Background Systemic inflammatory and autoimmune diseases (SIADs) occur in 10–20% of patients with myelodysplastic syndrome (MDS). Recently identified VEXAS…”
Get full text
Journal Article -
13
Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function
Published in Cancer chemotherapy and pharmacology (2003)“…p53 is the most frequently altered gene in human cancer. It was expected to be the principle marker for chemo/radiosensitivity, resistance, tumor recurrence…”
Get full text
Journal Article -
14
Fungal infections in patients with neutropenia : Challenges in prophylaxis and treatment
Published in Drugs & aging (01-11-2000)“…Fungal infections are a leading cause of mortality in patients with neutropenia. Candidiasis and aspergillosis account for most invasive fungal infections…”
Get full text
Journal Article -
15
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Published in International journal of cancer (20-08-2001)“…A woman with a family history of brain tumors in her daughter and sister presented with a breast cancer. She subsequently developed two metachronous primary…”
Get full text
Journal Article -
16
Long‐term survival in post‐transplant lymphoproliferative disorders with a dose‐adjusted ACVBP regimen
Published in British journal of haematology (01-09-2006)“…Summary Post‐transplant lymphoproliferative disorders (PTLD) are severe complications after solid organ transplantation with no consensus on best treatment…”
Get full text
Journal Article -
17
The lipid formulations of amphotericin B
Published in Expert opinion on pharmacotherapy (01-08-2003)“…Amphotericin B spectrum covers most of the fungal pathogens involved in human diseases. Its use is limited by infusion-related effects and nephrotoxicity. As a…”
Get more information
Journal Article -
18
Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study
Published in Clinical microbiology and infection (01-11-2021)“…To describe the coinfections in invasive aspergillosis (IA), to identify factors associated with coinfections, and to evaluate the impact of coinfection on…”
Get full text
Journal Article -
19
Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease
Published in Radiation oncology (London, England) (02-05-2013)“…To analyze the outcome and dose distribution of intensity-modulated radiation therapy (IMRT) by helical tomotherapy in women treated for large…”
Get full text
Journal Article -
20
Oral chemotherapy in colorectal cancer treatment: review of the literature
Published in European Journal of Internal Medicine (01-02-2003)“…Recent advances in anticancer treatment have focused on the development of oral anticancer agents with the intention of improving the patients’ quality of life…”
Get full text
Book Review Journal Article